pyrazolanthrone has been researched along with mycophenolic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, JW; Han, NJ; Kim, YJ; Lee, JM; Park, SK; Yang, WS | 1 |
2 other study(ies) available for pyrazolanthrone and mycophenolic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mycophenolic acid attenuates tumor necrosis factor-alpha-induced endothelin-1 production in human aortic endothelial cells.
Topics: Acetylcysteine; Anthracenes; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mycophenolic Acid; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2010 |